↓ Skip to main content

Statins for women with polycystic ovary syndrome not actively trying to conceive

Overview of attention for article published in Cochrane database of systematic reviews, October 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Statins for women with polycystic ovary syndrome not actively trying to conceive
Published in
Cochrane database of systematic reviews, October 2011
DOI 10.1002/14651858.cd008565.pub2
Pubmed ID
Authors

Amit D Raval, Tamara Hunter, Bronwyn Stuckey, Roger J Hart

Abstract

Statins, as lipid-lowering agents with pleiotropic actions, are likely not only to improve the dyslipidaemia associated with polycystic ovary syndrome but may also exert other beneficial metabolic and endocrine effects.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Brazil 1 1%
Ireland 1 1%
Unknown 84 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 20%
Student > Master 15 17%
Student > Doctoral Student 10 11%
Student > Ph. D. Student 9 10%
Unspecified 8 9%
Other 27 31%
Unknown 1 1%
Readers by discipline Count As %
Medicine and Dentistry 52 59%
Unspecified 9 10%
Agricultural and Biological Sciences 7 8%
Social Sciences 6 7%
Nursing and Health Professions 5 6%
Other 8 9%
Unknown 1 1%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2018.
All research outputs
#3,639,772
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,030
of 8,923 outputs
Outputs of similar age
#29,046
of 95,742 outputs
Outputs of similar age from Cochrane database of systematic reviews
#43
of 72 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,742 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.